Sheng‐Fong Kuo

1.2k total citations
42 papers, 892 citations indexed

About

Sheng‐Fong Kuo is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Sheng‐Fong Kuo has authored 42 papers receiving a total of 892 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Endocrinology, Diabetes and Metabolism, 18 papers in Surgery and 9 papers in Molecular Biology. Recurrent topics in Sheng‐Fong Kuo's work include Thyroid Cancer Diagnosis and Treatment (17 papers), Thyroid and Parathyroid Surgery (11 papers) and Head and Neck Anomalies (8 papers). Sheng‐Fong Kuo is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (17 papers), Thyroid and Parathyroid Surgery (11 papers) and Head and Neck Anomalies (8 papers). Sheng‐Fong Kuo collaborates with scholars based in Taiwan, United States and Japan. Sheng‐Fong Kuo's co-authors include Jen‐Der Lin, Chuen Hsueh, Tzu‐Chieh Chao, Li‐Wei Chen, Rong‐Nan Chien, Kun‐Chun Chiang, Horng‐Heng Juang, Chun‐Nan Yeh, Jong‐Hwei S. Pang and Chih‐Hung Chen and has published in prestigious journals such as PLoS ONE, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Sheng‐Fong Kuo

42 papers receiving 868 citations

Peers

Sheng‐Fong Kuo
Giuseppa Graceffa Italy
Bartolomeo Farzati Italy
E L Kaplan United States
Uğur Berberoğlu Türkiye
Saburo Murakami Japan
Sang Uk Woo South Korea
Ren-Xuan Guo China
Giorgio Zanette Italy
Joel Thompson United States
A. M. James Shapiro Canada
Giuseppa Graceffa Italy
Sheng‐Fong Kuo
Citations per year, relative to Sheng‐Fong Kuo Sheng‐Fong Kuo (= 1×) peers Giuseppa Graceffa

Countries citing papers authored by Sheng‐Fong Kuo

Since Specialization
Citations

This map shows the geographic impact of Sheng‐Fong Kuo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheng‐Fong Kuo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheng‐Fong Kuo more than expected).

Fields of papers citing papers by Sheng‐Fong Kuo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sheng‐Fong Kuo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheng‐Fong Kuo. The network helps show where Sheng‐Fong Kuo may publish in the future.

Co-authorship network of co-authors of Sheng‐Fong Kuo

This figure shows the co-authorship network connecting the top 25 collaborators of Sheng‐Fong Kuo. A scholar is included among the top collaborators of Sheng‐Fong Kuo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sheng‐Fong Kuo. Sheng‐Fong Kuo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Lin, Yu‐Ching, Jim S. Wu, Sheng‐Fong Kuo, et al.. (2019). Vertebral Fractures in Type 2 Diabetes Patients: Utility of Trabecular Bone Score and Relationship With Serum Bone Turnover Biomarkers. Journal of Clinical Densitometry. 23(1). 37–43. 18 indexed citations
3.
Lin, Jen‐Der, et al.. (2018). The efficacy of radioactive iodine for the treatment of well-differentiated thyroid cancer with distant metastasis. Nuclear Medicine Communications. 39(12). 1091–1096. 14 indexed citations
4.
Chiang, Kun‐Chun, Chun‐Nan Yeh, Ta‐Sen Yeh, et al.. (2018). MART-10, a 1α,25(OH)2D3 Analog, Potently Represses Metastasis of ER+ Breast Cancer Cells with VEGF-A Overexpression. Anticancer Research. 38(7). 3879–3887. 8 indexed citations
5.
Kuo, Sheng‐Fong, et al.. (2017). Therapeutic Outcomes of Patients with Multifocal Papillary Thyroid Microcarcinomas and Larger Tumors. International Journal of Endocrinology. 2017. 1–8. 23 indexed citations
6.
Kuo, Sheng‐Fong, Tsung‐Ying Ho, Miaw‐Jene Liou, et al.. (2017). Higher body weight and distant metastasis are associated with higher radiation exposure to the household environment from patients with thyroid cancer after radioactive iodine therapy. Medicine. 96(35). e7942–e7942. 4 indexed citations
7.
Chiang, Kun‐Chun, Chun‐Nan Yeh, Jong‐Hwei S. Pang, et al.. (2017). 1α,25(OH)2D3 Analog, MART-10, Inhibits Neuroendocrine Tumor Cell Metastasis After VEGF-A Stimulation. Anticancer Research. 37(11). 6215–6221. 4 indexed citations
8.
Chen, Fang‐Ping, et al.. (2017). Association between metabolic syndrome and bone fracture risk. Medicine. 96(50). e9180–e9180. 12 indexed citations
9.
Chen, Liwei, Chia‐Wen Hsieh, Liang‐Che Chang, et al.. (2016). The Associations Between Helicobacter pylori Infection, Serum Vitamin D, and Metabolic Syndrome. Medicine. 95(18). e3616–e3616. 21 indexed citations
10.
Chiang, Kun‐Chun, Chun‐Nan Yeh, Huang-Yang Chen, et al.. (2015). PTEN insufficiency modulates ER+ breast cancer cell cycle progression and increases cell growth in vitro and in vivo. Drug Design Development and Therapy. 9. 4631–4631. 7 indexed citations
11.
Chiang, Kun‐Chun, Sheng‐Fong Kuo, Chih‐Hung Chen, et al.. (2015). MART-10, the vitamin D analog, is a potent drug to inhibit anaplastic thyroid cancer cell metastatic potential. Cancer Letters. 369(1). 76–85. 33 indexed citations
12.
Kuo, Sheng‐Fong, Tzu‐Chieh Chao, Hung‐Yu Chang, et al.. (2015). Prognosis of papillary thyroid cancers with positive serum thyroglobulin antibody after total thyroidectomy. Asian Journal of Surgery. 40(3). 186–192. 11 indexed citations
13.
14.
Chiang, Kun‐Chun, Chun‐Nan Yeh, Jun‐Te Hsu, et al.. (2014). The vitamin D analog, MART-10, represses metastasis potential via downregulation of epithelial–mesenchymal transition in pancreatic cancer cells. Cancer Letters. 354(2). 235–244. 46 indexed citations
15.
Chiang, Kun‐Chun, Shin‐Cheh Chen, Chun‐Nan Yeh, et al.. (2013). MART-10, a less calcemic vitamin D analog, is more potent than 1α,25-dihydroxyvitamin D3 in inhibiting the metastatic potential of MCF-7 breast cancer cells in vitro. The Journal of Steroid Biochemistry and Molecular Biology. 139. 54–60. 32 indexed citations
16.
Chiang, Kun‐Chun, Chun‐Nan Yeh, Jun‐Te Hsu, et al.. (2013). MART-10, a novel vitamin D analog, inhibits head and neck squamous carcinoma cells growth through cell cycle arrest at G0/G1 with upregulation of p21 and p27 and downregulation of telomerase. The Journal of Steroid Biochemistry and Molecular Biology. 138. 427–434. 34 indexed citations
17.
Sun, Chi‐Chin, et al.. (2012). Axial Length and Proliferative Diabetic Retinopathy. Optometry and Vision Science. 89(4). 465–470. 12 indexed citations
18.
Wu, Huang-Pin, et al.. (2010). High interleukin-12 production from stimulated peripheral blood mononuclear cells of type 2 diabetes patients. Cytokine. 51(3). 298–304. 17 indexed citations
19.
Lin, Jen‐Der, Tzu‐Chieh Chao, Chuen Hsueh, & Sheng‐Fong Kuo. (2009). High Recurrent Rate of Multicentric Papillary Thyroid Carcinoma. Annals of Surgical Oncology. 16(9). 2609–2616. 88 indexed citations
20.
Lin, Jen‐Der, Sheng‐Fong Kuo, Tzu‐Chieh Chao, & Chuen Hsueh. (2008). Incidental and Nonincidental Papillary Thyroid Microcarcinoma. Annals of Surgical Oncology. 15(8). 2287–2292. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Giuseppa Graceffa Breakdown of academic impact, for papers by Bartolomeo Farzati Breakdown of academic impact, for papers by E L Kaplan Breakdown of academic impact, for papers by Uğur Berberoğlu Breakdown of academic impact, for papers by Saburo Murakami Breakdown of academic impact, for papers by Sang Uk Woo Breakdown of academic impact, for papers by Ren-Xuan Guo Breakdown of academic impact, for papers by Giorgio Zanette Breakdown of academic impact, for papers by Joel Thompson Breakdown of academic impact, for papers by A. M. James Shapiro
Rankless by CCL
2026